Drug Profile
VG 1177
Alternative Names: APi 1177; VG-1177; VGV-XLatest Information Update: 23 Feb 2023
Price :
$50
*
At a glance
- Originator Viral Genetics
- Developer University of Utah; VG Life Sciences
- Class Anti-inflammatories; Antiepileptic drugs; Antihypertensives; Antiretrovirals; Peptides
- Mechanism of Action Immunomodulators; Invariant chain inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Brain injuries; Epilepsy; HIV infections; Inflammatory bowel diseases; Preeclampsia
Most Recent Events
- 23 Feb 2023 Discontinued - Preclinical for Brain injuries in Canada (Parenteral) (VG Life Sciences website, February 2023)
- 23 Feb 2023 Discontinued - Preclinical for Epilepsy in USA (Parenteral) (VG Life Sciences website, February 2023)
- 23 Feb 2023 Discontinued - Preclinical for HIV infections in Canada (Parenteral) (VG Life Sciences website, February 2023)